Group 1 - The Shanghai Composite Index is at 3575.26 points with a slight increase of 0.06% and total A-share trading volume is 735.89 billion yuan [1] - A total of 55 A-shares have seen their 5-day moving average cross below the 10-day moving average, indicating potential bearish trends [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include Tongzhou Electronics at -1.19%, Marubi Biological at -0.82%, and Everbright Jiabao at -0.61% [1] Group 2 - Additional stocks showing a downward trend in their moving averages include Ge Ke at -0.61%, Hisense at -0.57%, and Beichen at -0.55% [1] - Other companies with notable moving average crossovers include Wan Shi at -0.53%, Baoling at -0.50%, and Zhejiang University at -0.49% [1] - The report also highlights stocks like PAI Neng and ST Zhong with minor declines in their moving averages, indicating a broader trend in the market [1]

Summary of Key Points Core Viewpoint - The announcement details the results of a share reduction plan by major shareholders of Guangda Jiabao Co., Ltd, indicating that the plan has been successfully executed with a total reduction of 14,987,800 shares, representing 1% of the company's total share capital [1]. Group 1: Shareholder Information - Shanghai Jiading Jianye Investment Development Co., Ltd. (Jianye) held 154,180,120 shares, accounting for 10.28% of the total share capital before the reduction [1][2]. - Shanghai Jiading Technology Investment (Group) Co., Ltd. (Jian Technology) held 87,041,986 shares, representing 5.80% of the total share capital before the reduction [1][2]. - Jianye and Jian Technology are acting in concert, collectively holding 241,222,106 shares, which is 16.08% of the total share capital [1][3]. Group 2: Reduction Plan Implementation - The reduction plan was first disclosed on March 27, 2025, with a maximum reduction of 14,996,854 shares planned over three months [1]. - Jianye reduced its holdings by 7,497,800 shares between May 7, 2025, and July 18, 2025, at a price range of 2.95 to 3.15 CNY per share, totaling approximately 22.77 million CNY [3]. - Jian Technology reduced its holdings by 7,490,000 shares on May 6, 2025, at a price range of 2.79 to 2.81 CNY per share, totaling approximately 20.92 million CNY [3]. - The total reduction by both shareholders was completed as planned, with each reducing their holdings by 0.5% of the total share capital [3].

证券代码：600622 股票简称：光大嘉宝 公告编号：临 2025-052 光大嘉宝股份有限公司 关于持股 5%以上股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 大股东持股的基本情况 本次减持计划实施前，上海嘉定建业投资开发有限公司（以下简称"嘉定建 业"）持有光大嘉宝股份有限公司（以下简称"公司、本公司"）无限售条件流通 股 154,180,120 股，占公司总股本的 10.28%。上海嘉定科技投资（集团）有限 公司（原企业名称上海嘉定科技投资有限公司，以下简称"嘉定科投"）持有公 司无限售条件流通股 87,041,986 股，占公司总股本的 5.80%。嘉定建业与嘉定 科投为一致行动人，合计持有公司无限售条件流通股 241,222,106 股，合计占公 司总股本的 16.08%。 减持计划的实施结果情况 公司于 2025 年 3 月 27 日披露了《关于持股 5%以上股东减持股份计划公告》， 嘉定建业与嘉定科投计划自上述公告披露之日起满 15 个交易日后的 3 个月内， 通 ...

Meeting Details - The shareholders' meeting of Everbright Jiabao Co., Ltd. was held on May 18, 2025, in Shanghai [1] - The total proportion of shares held by attending ordinary shareholders and preferred shareholders with restored voting rights was 47.6866% [1] Voting Process - The meeting was chaired by the vice chairman, Mr. Su Xiaopeng, and utilized a combination of on-site and online voting methods, complying with the Company Law and Articles of Association [1] - The non-cumulative voting proposal was approved with 99.3817% of A-share votes in favor, totaling 710,727,579 votes [1] Legal Compliance - The lawyers, Ru Qiule and Zhu Xiaoming, confirmed that the convening and holding of the shareholders' meeting complied with relevant laws and regulations, and the voting results were deemed valid [1]

上海市通力律师事务所关于光大嘉宝股份有限公司 2025 年第六次临时股东大会的法律意见书 致:光大嘉宝股份有限公司 上海市通力律师事务所(以下简称"本所")接受光大嘉宝股份有限公司(以下简称"公 司")的委托,指派本所朱晓明律师、茹秋乐律师(以下简称"本所律师")根据《中华人民共 和国公司法》《中华人民共和国证券法》等法律、法规以及规范性文件(以下统称"法律法 规")及《光大嘉宝股份有限公司章程》(以下简称"公司章程")的规定就公司 2025 年第六 次临时股东大会(以下简称"本次股东大会")相关事宜出具法律意见。 本所律师已经对公司提供的与本次股东大会有关的法律文件及其他文件、资料予以了 核查、验证。在进行核查验证过程中,公司已向本所保证,公司提供予本所之文件中的所有 签署、盖章及印章都是真实的,所有作为正本提交给本所的文件都是真实、准确、完整和有 效的,且文件材料为副本或复印件的,其与原件一致和相符。 在本法律意见书中,本所仅对本次股东大会召集和召开的程序、出席本次股东大会人员 资格和召集人资格及表决程序、表决结果是否符合法律法规和公司章程的规定发表意见,并 不对本次股东大会所审议的议案内容以及该等议案所 ...

2025年第六次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 7 月 18 日 (二)股东大会召开的地点：上海市嘉定区依玛路 333 弄 1-6 号 305 室 证券代码：600622 股票简称：光大嘉宝 公告编号：临 2025-051 光大嘉宝股份有限公司 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 625 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 715,149,210 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 47.6866 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集。根据公司有关规定及相关实际情况，本次股东 大会由公司副董事长苏晓鹏先生主持。本次股东大会采取现场 ...

A股房地产板块快速下挫，绿地控股封板跌停，渝开发、南山控股、财信发展、光大嘉宝跟跌。 ...

China Everbright Jiabao Co., Ltd. 2025 Semi-Annual Performance Forecast [Current Period Performance Forecast](index=1&type=section&id=Item%201.%20Current%20Period%20Performance%20Forecast) The company forecasts a net loss for H1 2025, with attributable net profit between **-350 million and -400 million CNY**, representing an expanded loss 2025 H1 Performance Forecast vs. 2024 H1 | Indicator | 2025 H1 Forecast | 2024 H1 | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders (CNY 10,000) | -35,000.00 to -40,000.00 | -32,758.79 | | Net Profit Attributable to Shareholders After Non-recurring Items (CNY 10,000) | -37,300.00 to -42,300.00 | -32,297.83 | - This performance forecast applies to situations where net profit is negative, and the data represents preliminary estimates by the company's finance department, unaudited by an accounting firm[4](index=4&type=chunk)[5](index=5&type=chunk) [Operating Performance and Financial Status for the Same Period Last Year](index=2&type=section&id=Item%202.%20Operating%20Performance%20and%20Financial%20Status%20for%20the%20Same%20Period%20Last%20Year) The company disclosed restated 2024 H1 financial data, reporting a net loss attributable to shareholders of **-327.59 million CNY** and EPS of **-0.22 CNY** 2024 Same Period Financial Data | Indicator (2024 Same Period) | Amount | | :--- | :--- | | Total Profit (CNY 10,000) | -24,912.05 | | Net Profit Attributable to Owners of the Parent Company (CNY 10,000) | -32,758.79 | | Net Profit Attributable to Owners of the Parent Company After Non-recurring Items (CNY 10,000) | -32,297.83 | | Earnings Per Share (CNY) | -0.22 | - The company notes that prior period data has been restated due to retrospective adjustments[7](index=7&type=chunk) [Primary Reasons for Current Period's Expected Loss](index=2&type=section&id=Item%203.%20Primary%20Reasons%20for%20Current%20Period%27s%20Expected%20Loss) The 2025 H1 loss is attributed to consolidated fund projects' financial losses and real estate investment projects' equity method losses - Consolidated fund projects incurred financial losses due to the inclusion of finance costs and depreciation[8](index=8&type=chunk) - Certain real estate investment projects are still in their incubation phase, resulting in recognized investment losses accounted for under the equity method[8](index=8&type=chunk) [Risk Warning](index=2&type=section&id=Item%204.%20Risk%20Warning) This preliminary, unaudited performance forecast is subject to the final 2025 semi-annual report, advising investors to note investment risks - This performance forecast represents preliminary calculations by the company's finance department based on its professional judgment and has not yet been audited by a certified public accountant[9](index=9&type=chunk) - The final accurate financial data will be based on the company's officially disclosed 2025 semi-annual report, and investors are advised to be aware of investment risks[10](index=10&type=chunk)

光大嘉宝（600622）公告，预计2025年半年度实现归属于母公司所有者的净利润-3.5亿元到-4亿元，上 年同期为-3.28亿元；预计2025年半年度实现归属于母公司所有者的扣除非经常性损益后的净利润-3.73 亿元到-4.23亿元。 ...

New Stock Issuance - Shanda Electric (Stock Code: 301609) issued at a price of 14.66[1] - Jiyuan Group (Stock Code: 732262) issued at a price of 10.88[1] Market Alerts - Jichuan Pharmaceutical (Stock Code: 600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - The last trading day for Tuisan Jinguang (Stock Code: 600190) is July 14, 2025, with 4 trading days remaining[1] - The last trading day for Tuisan Jinjing (Stock Code: 900952) is also July 14, 2025, with 4 trading days remaining[1] Abnormal Fluctuations - *ST Zitian (Stock Code: 300280) reported severe abnormal fluctuations on July 10, 2025[1] - *ST Yushun (Stock Code: 002289) reported abnormal fluctuations on July 11, 2025[1] Other Notable Announcements - Longyuan Green Energy (Stock Code: 603185) announced on July 11, 2025[1] - Kedi Pharmaceutical (Stock Code: 000590) announced on July 14, 2025[1]